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ABSTRACT
Background: There are many foci endemic for Schistosoma (S.) mansoni in Uganda. 
The immune responses to infection with the parasites in these areas have been found 
to vary with host sex, age and infection intensity. 
Objective: To determine the profile of antibody isotypes responses against S. mansoni 
crude soluble egg antigens (SEA) and soluble adult worm protein (SWAP) antigens 
that determine the host resistance or susceptibility to reinfection. 
Design: Cross Sectional, cohort study.
Setting: Kigugu fishing village in Entebbe, Uganda. 
Subjects: Nine hundred and forty five (945) Kigungu residents reported for pre-treatment 
screening and enrolment and 626 cohorts report for post-treatment screening and 
enrolment 18 months later. 
Results: Pearson’s Chi-sq2 showed that increase in titres of anti (SWAP IgE, SEA IgE, and 
SEA IgG2) was not significant, but increase in anti SEA IgG3 was significant. Decrease 
in titres of anti (SWAP IgG1, SEA IgG1, and SEA IgG4) was not significant but decrease 
of anti (SWAP IgG2, SWAP IgG3 and SWAP IgG4) was significant. Positive correlation 
existed between age and anti SWAP IgE in before and after treatment sera. On the 
contrary, age was positively correlated with anti SWAP IgG4 in pre-treatment sera but 
was negatively correlated with anti SWAP IgG4 in the post-treatment sera. In addition 
there were positive correlation between higher egg counts and the immunoglobulin 
levels of anti SWAP IgG4 and anti SEA IgG4 but negative correlations were observed 
between anti SWAP IgE and anti SEA IgE. Conversely low egg counts were associated 
with high levels of anti SWAP IgE. Furthermore, IgG1-4, IgE antibody to SEA and 
SWAP antigens did not differ significantly according to sex. 
Conclusion: We concluded that praziquantel treatment of S. mansoni infected persons 
alter the immune responses that are influenced by age and intensity. A phenomenon 
that is useful in the effort to produce vaccine against schistosome. 
INTRODUCTION 
Studying the immune responses of the hosts to 
Schistosoma mansoni infection bridges the gaps in our 
knowledge about the anti parasite antibody responses 
to the parasite antigens of people living in the endemic 
areas. Previous studies from endemic areas in this 
respect have shown that specific antibody isotype 
responses against the parasite can promote either 
resistance or susceptibility to reinfection (1, 2).  High 
level of IgE antibodies against soluble adult worm 
protein (SWAP) antigen in the blood is associated with 
resistance to infection or reinfection while high level 
of anti SWAP IgG4 is associated with susceptibility 
to infection or reinfection (2,3).  The various antigens 
in different life stages of S. mansoni in the human 
host elicit multiple antibody responses during the 
transition period from acute to chronic stages of the 
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disease (4). In the acute toxaemic phase of Schistosoma 
mansoni infections, levels of specific humoral Ig 
responses against (SEA) are higher than in (SWAP). 
Whereas, in chronic schistosomiasis, specific epitope 
Sm22.6 found in adult worms antigens component 
is a target for the production of protective IgE. The 
expression of protective immunity therefore depends 
on the favourable balance towards IgE production in 
the chronic infections and IgG 4 produced in acute 
infection. Beside IgE, mast cells coated with IgG when 
stimulated with antigens would lead to production 
of protective antibodies in the entire IgG sub-classes 
and the release of eosinophils chemotactic factors 
(4).  In endemic areas, periodic treatments with anti-
schistosomal drugs have been found to alter immune 
responses, associated with resistance to reinfection 
in children above 15 years and adults (2, 5). On the 
contrary, children between five to ten years continue 
to be highly susceptible to post treatment reinfections 
(6). These differences in immune responses in adults 
and children of endemic areas have been established 
to be due to high levels of specific IgE in adults that 
confer resistance to reinfections after treatments 
(2, 7). Sex has little influence on the production of 
immunoglobulin but age and intensity of infection 
have been shown to correlate positively with the 
immune responses (2). IgE and IgA mediate resistance 
in adults while IgG2c, IgG4 and IgM are associated 
with susceptibility especially in young patients (8). 
IgG4 is known to interfere with IgE combining site on 
the schistosomulum thus preventing IgE from binding 
to the high affinity receptor (FceRI) on eosinophil. In 
addition, the interference of IgG2c and IgM at the 
binding sites of IgG1, IgG2a and IgG3 prevent the 
attachment of these cytophilic immunoglobulins 
receptor on eosinophils and therefore reduce their 
defensive role in inducing eosinophil mediating 
killing of schistosomula (1).   
 Following the previously mentioned studies, 
we investigated immune responses of people living 
in Kigungu fishing village Uganda before and after 
therapy with praziquantel after 18 months instead 
of the usual six to one year period used in most of 
the previous studies (1-3). We still found high level 
of the antibodies in the patients’ sera. 
MATERIALS AND METHODS
 
Study area: This study was conducted in Kigungu 
fishing village, situated along Lake Victoria in 
Entebbe peninsula. It is located at latitude 435 
to 438 East and 003 to 007 North. It is about 15 
kilometres from Entebbe Municipality and about 
half a kilometre from the Entebbe International 
airport. This fishing village was selected because it 
has base line data on prevalence and intensities of 
S. mansoni and other soil-transmitted helminths (9). 
The population of Kigungu is estimated to be 6,000 
people with nearly an equal sex 1:1 ratio. The main 
economical activity of the inhabitants is fishing with 
limited subsistence farming mainly for food crops. 
Their water exposure is high. Hence, the source of 
infections and reinfections with S.mansoni.  
Study population and study design: An inception cohort 
of 945 participants of adults and children, residents 
of Kigungu fishing village were enrolled in this study 
and evaluated over time for S.mansoni infections. 
Two cross sectional assessments performed within 
a period of 18 months, one before and other after 
treatment. The first evaluation included the 945 
participants, while only 626 returned for the 
second evaluation after 18 months. Participants’ 
identifications were based on unique study code 
numbers, names, sex, age, home locations and the 
names of head of the families. The immunoglobulins 
levels in sera taken before and after treatment were 
correlated with age, egg counts and sex. The age of 
study patients ranged from 5 to 60 years (mean age 
was 19 years and median 33.5 years). These were 
adults who have consented to participate in the study, 
and children between five and 18 years with parental 
permission to participate in the study. All registered 
participants had no anti-schistosomal treatment 
six months prior this study. We set an outreach 
clinic, which was used as recruitment centre for the 
study in Kigungu Primary school. Medical doctors, 
and nurses, carried out medical examinations 
and recorded the clinical symptoms, while four 
experienced Medical Laboratory Technologists 
carried out laboratory investigations. A social 
worker undertook recruitments, and explaining the 
benefit of the study to the participants before and 
after treatment.  The general physical examination 
included status of the abdominal organs commonly 
affected by S. mansoni . Patients with fever, and body 
temperature greater than 37.50C had blood smear test 
for malaria parasites done. On each working day, 
approximately thirty patients were enrolled into the 
study. The daily enrolment was deliberately limited 
to thirty patients to allow satisfactory processing of 
the patients’ stool samples and treatment of cases 
the following day. Those patients who were S. 
mansoni egg positive were treated with praziquantel 
at single oral dose of 40 mg/kg body weight within 
our study centre. 
Laboratory procedures- Stool microscopic examination 
was performed using modified Kato-Katz method as 
described previously (10, 11) and in following studies. 
The arithmetic mean of the eggs counted in three slides 
was recorded as the count in 41.7 milligram of stool. 
To convert the mean egg counted into egg per gram 
of faeces a factor of 24 was multiplied by the mean 
of the eggs counted, {that is, (number of eggs x 1000 
mg per g)/ (41.7 mg) = 24 x number of eggs/g}. 
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Antibody study: Optimised indirect enzyme-linked 
immunosorbent assay, (ELISA) system using 
horseradish peroxidase (HRP) was used to detect 
and quantify antibody isotypes IgG1, IgG2, IgG3, 
IgG4 and IgE levels in the sera of 183 participants 
whose blood samples were taken at the recruitment 
and 18 months after. Crude  extract of soluble  adult 
worm protein antigen (SWAP) and soluble egg 
antigens (SEA) provided by Centro de Pesquisas Rene 
Rachou-Fiocruz Laboratory de Immunlogia Cellular 
de Molecular, Av.Augusto de Lima 1715 Barro Preto 
CEP 30190-002 Belo Horizonte, Minas Gerais, Brazil 
were used in the study. The  surfaces of the wells of 
microtiter plates (NUNC-IMMUNOTM plate Nalge 
Nunc International, Denmark), were coated with 
these  antigens  diluted in carbonate-bicarbonate 
buffer, (0.05M, pH 9.6) to constitute 100 ng / 100 μl 
of antigen per well. The plates were incubated at 
40C overnight to allow the antigen to bind on the 
surface of wells of the plates (after every subsequent 
incubation the plates were washed using PBS pH 
7.4 containing 0.05% Tween 20 in   ELISA washer 
(812 SW1, SLT No 08139 laboratory instruments 
Strasbourg-Schiltgheim, France). Later 100 µl of 
1% bovine serum albumin (BSA) blocking agent 
from (Sigma Aldrich Chemie Gmbh P.O. 1120 89552 
Steinheim Germany 49-7329-979) in buffer (PBS) 
pH 7.4/ containing 0.05% Tween 20 was added. 
Plates were incubated at room temperature (RT) for 
2.5 hours. Diluted human serum in 100 µl volume 
(primary/ detecting antibody) was titrated using 
doubling master titration. Plates were sealed and 
incubated at 40C overnight to allow antibody to bind 
to the antigen in the plates. Anti-human biotinylated 
mouse monoclonal antibody isotype (secondary 
antibody) to human sub-classes IgG1, IgG2, IgG3 
and IgG4 from Zymed Laboratory, INC.48 Carlton 
Court So.San Francisco, CA 94080  was diluted at 
1:1000 in phosphate buffer saline pH 7.4 containing 
0.05% Tween 20. The diluted biotinylated mouse 
monoclonal anti-human globulins was mixed with 
Streptavidine conjugated to horseradish peroxidase 
diluted 1:5000(ECL Amershham Pharmacia Biotech 
AB Inc.800 Centennial Avenue P.O.Box 1327 
Piscataway NJ 08855 USA). In addition, 100 µl 
of the mixture of mouse monoclonal anti-human 
biotinylated/streptavidine horseradish peroxidase 
was added to each well in the plate. Plates were 
incubated at (RT) for two and a half hours and 
later washed in PBS pH 7.4/ plus 0.05% Tween 
20 for five cycles to remove the unbound mouse 
monoclonal anti- human biotinylated/streptavidine. 
Chromogen Ortho-phenylene diamine (OPD) (Sigma 
Chemicals CO. P. O. Box 14508 St.Louis  MO 63178 
USA 314771-5750 , and 30% substrate  hydrogen 
peroxide  pre-determined volume according to the 
total volume require for the test in citric acid buffer 
pH 5 was added in 100 µl volume to all wells to bind 
to horseradish peroxidase /streptavidine in the plate. 
Plates were then incubated at room temperature in a 
dark cupboard for 30 minutes for colour to develop. 
After which colour development was stopped using 
50 µl of 5M Sulphuric Acid added to each well.  The 
Optical density was measured at absorbance 492 
nmm in an automated ELISA reader (SLT Sandberg 
& Schneidewind Stormsweg 5*22085 Hamburg* 
Germany) and the reading printed out using Dot 
Matrix printer Star Micronics manufacturing UK.Ltd 
no 423010482251. 
Statistical Analysis- There was lack of normality in the 
frequency distributions of all variables and as well 
as varying forms of non-linearity in the relationships 
of specific antibody isotype with age and egg count. 
Analysis therefore consisted of the following: 
Pearson’s Chi-sq2 was used to test associations between 
categorical variables; antibody vs. (age, egg count, 
and sex) data in levels of S. mansoni (anti-SWAP 
or anti-SEA) antibody isotypes in pre and post 
treatment sera at 95% level of confidence. Spearman’s 
rank correlation was utilised to examine quantitative 
correlations between S. mansoni stool egg count, 
antibody isotypes and age in non-parametric data. 
All statistical analysis was carried out using SPSSv10, 
Micsoft Excel, GraphPad software and Stata SE8.
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RESULTS
The reciprocal mean titre of specific antibody isotypes of 183 participants whose blood samples were taken 
at the recruitment and 18 months after against SWAP antigens are shown in Figure 1.
Figure 1 
The mean titre of different antibodies IgE and IgG1-4 against SWAP antigens before and after treatment
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Mean titre of different anti- SWAP among 183 
patients before  and after treatment.  The reciprocal 
mean titre of anti-SWAP IgE increase from 1: 
191 to 1: 660 after treatment was not significant 
(P=0.946). Anti-SWAP IgG1 decreased from 1: 2112 
to 1: 1457 after treatment but the decrease was not 
significant (P=0.335). Anti-SWAP IgG2 decreased 
significantly (P<0.0001) from 1: 261 to 1: 99 after 
treatment. Anti-SWAP IgG3, also significantly 
(P< 0.044) decreased from 1: 4043 to 1: 2313 
after treatment. Anti- SWAP IgG4 significantly 
decreased (P<0.0001) from 1: 2003 to 1: 1778 after 
treatment. The bars are standard error bars SE at 
95% Confident Interval (CI).
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Figure 2
The reciprocal mean titre of different antibodies IgE and IgG1-4 against SEA antigens before and after treatment
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 The reciprocal mean titre of specific antibody isotypes 
of 183 participants whose blood samples were taken 
at the recruitment and 18 months after against SEA 
antigens are shown in Figure 2.
 Mean titre of different anti- SEA among 183 
patients before =   and after treatment =.  The level of 
anti SEA IgE remained high after treatment and the 
titre  increased from 1: 3665 to 1:4296 but the increase 
was not significant (P=0.605). Anti-SEA IgG1 decrease 
from 1: 1617 to 1:1596 was not significant (P=0.116). 
Anti-SEA IgG2 slightly increased from 1: 330 to 1: 
395 but the increase was not significant (P=0.199). 
Anti-SEA IgG3 significantly (P <0.0001) increased 
from 1: 2621 to 1: 2909 after treatment. Anti- SEA IgG4 
also decreased but the decrease was not significant 
(P=0.019) from 1: 1297 to 1: 556 after treatment. The 
bars are standard error bars SE at 95% Confident 
Interval (CI).
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Figures 3
The association between anti SWAP IgE and age before and after Praziquantel chemotherapy
     
Relationship between anti-SWAP (IgE, IgG4) and age in per and post treatment sera A and B 
Key: Sera taken before treatment = A and sera taken after treatment = (B). OD= optical density (3 +Log10 OD) 
at 492 nmm. y = equation to determine the position of the best line of fit indicated by the black line. 
R2 = coefficient correlations measure how strongly the values of x are related to values of y; the levels of 
anti- SWAP IgE was lower in sera A  but was positively correlated to age.
Figure 4
The association between anti SWAP (IgG4) and age before and after Praziquantel chemotherapy
(A) Pre  treatmentcorrelation between  anti- SWAP IgG4 and age 
























Key: Sera taken before treatment = A and sera taken after treatment = (B). OD= optical density (3 +Log10 OD) 
at 492 nmm. y = equation to determine the position of the best line of fit indicated by the black line. 
R2 = coefficient correlations measure how strongly the values of x are related to values of y; the level of anti- 
SWAP IgG4 was negatively correlated to age in sera B. 
(A) Pre- treatment correlation betwaeen age and anti SWAP IgE





















(B)Post treatment correllation between age and anit SWAP IgE  

























(B) Post treatment correlation between anti- SWAP IgG4 and age.
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Figure 5
Anti SEA IgG4 and age before and after Praziquantel chemotherapy
Relationship between anti-SEA (IgE, IgG4) and age in per and post treatment sera A and B
Key: A1 and A2=patients with S.mansoni before and after treatment; B1=Patient with S.mansoni before 
treatment and B2 are S.mansoni negative after treatment. OD= optical density (Log10) at 492 nmm; 
y = equation to determine the position of the best line of fit indicated by the black line; R2 = coefficient 
correlations measure how strongly the values of x are related to values of y; · = every dot represents value 
of absorbance individual serum.
Figure 6
Anti SEA IgE and age before and after Praziquantel chemotherapy
 
Key: B1 and B2=patients with S.mansoni before and after treatment; B1=Patient with S.mansoni before 
treatment and B2 are S.mansoni negative after treatment. OD = optical density (Log 1/sqrt) at 492 nmm; 
Y = equation to determine the position of the best line of fit indicated by the black line; R2 = coefficient 
correlations measure how strongly the values of x are related to values of y; · = every dot represents value 
of absorbance individual serum.
A2 Aftre treatment anti SEA IgG4 and age

































A1Before treatment anti SEA IgG4 and Age





































B2 After treatment anti SEA IgE  and age
































B1 Before treatment anti SEA IgE  and age
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DISCUSSION
Using the optimised indirect (ELISA), Horse 
radish peroxidase (HRP) system to detect and 
quantify antibody isotypes is sera of individuals 
with schistosome, many investigators have 
demonstrated high level of anti SWAP IgE in 
the blood of older children ≥15 years and adults 
which is believe to confer immunity whereas high 
level of anti SWAP IgG4 especially in children 
<15 is associated with susceptibility to infection 
or reinfection. These types of immune responses 
have commonly been observed in S. mansoni 
endemic areas (2-6). Praziquantel treatment of 
the participants in Kigungu resulted in changes 
in S. mansoni specific antibody responses directed 
towards soluble adult worm protein antigen (SWAP) 
and soluble egg antigens (SEA). After treatment, 
mean titre of serum anti SWAP IgE, increased, 
while anti SWAP IgG4 decreased. Because of the 
effectors functions of anti IgE and anti IgG4 on 
host immune responses as demonstrated before in 
other studies (2, 12), we illustrated association of 
the same immunoglobulins to age, and intensity.
 These changes were largely correlated with 
age. In Kigungu, children aged between 11-19 years 
were more infected with Schistosoma mansoni than 
the adults  ≥ 20 years of age in before and after 
treatment study. This age group also excreted 
the higher number of egg than the later  in both 
evaluation studies as have been shown previously 
in many studies (2, 13).  Some of these studies 
have shown that in Schistosoma mansoni endemic 
areas, there is distinction between age dependent 
resistance to reinfection after treatment between 
adults and children (6, 7). In this study it was 
show that children in Kigungu in their teens, 
which peak at 15 years of age, are more intensely 
infected and reinfected after treatment with the 
parasite than adults (Figs.3-6). In spite the fact that 
water exposures activities to infections in adults 
in Kigungu are more intense than the children. 
The current explanation for this phenomenon is 
that high levels of blocking antibodies like IgM, 
IgG4 and IgG2c which allow for susceptibility are 
present in these children’s blood (5, 12). Acquired 
immunity to schistosomiasis mansoni in children 
develops slowly with age owing to decrease in the 
level of the blocking antibodies and the increase 
of the amount of antigens in circulations due to 
frequent exposure to infections (6). As the children 
accumulate the schistosome antigenic material in 
their blood over the years, specific antibodies to 
these antigens also rise in their blood (14).
 We observed in the study that anti SWAP IgG4 
anti and SWAP IgE was positively correlated with 
age in pre and post treatment sera respectively 
(figs.3,4). In contrast anti SWAP IgG4 and anti SEA 
IgG4 were negatively correlated to age. Likewise, 
infection intensity was positively correlated to 
anti SWAP IgG4 and SEA IgG4. But anti SWAP 
IgE and anti SEA IgE, was negatively correlated 
with intensity of infection. Sex was not related to 
immunoglobulin levels, as was previously reported 
(2, 15). Resistance to re-infections has been shown to 
be due to development of high level of anti SWAP 
IgE. Whereas the levels of anti SWAP IgE and anti 
SEA IgE increased among the people of Kigungu 
after treatment the mean titres of anti SWAP 
IgG4 declined. The decrease of anti SWAP IgG4 
and anti SEA IgG4 after therapy was significant. 
The high titre of most anti SWAP and anti SEA 
antibodies in sera taken before treatment is due 
to high amount of worm load and eggs excreted 
by the female worms in the host initially (2, 15). It 
has been suggested in other studies that humoral 
immunity develops slowly against antigens from 
all life stages of S. mansoni. That a 22kDa antigen 
in S. mansoni, which stimulates the production of 
IgE is localised underneath the tegument of adult 
schistosome worms and that a good amount of 
this antigens are released by the dead worms to 
the immune systems of the hosts after treatment. 
They further suggested that the increased level of 
IgG4 antibodies whose production is regulated by 
the same cytokines, which regulate IgE production, 
is from the same antigens located underneath the 
tegument of the adult worms. The activity of the 
two antibodies is believed to be related, with IgG4 
acting as regulator of the allergic anaphylactic 
responses related to IgE (2, 16). In these studies, 
the level of anti SWAP IgG4 dropped while anti 
SWAP IgE increased with age. The phenomenon 
observed in this study suggests that anti SWAP 
IgE conferred immunity in older children and 
adults as was earlier reported (17). However lack 
of base line data on this type of study in S.mansoni 
endemic areas of Uganda especially this study 
area to compare with our  findings make the 
interpretation of these findings difficult.
 Intensity of infection was independently 
correlated to different antibody isotypes. Positive 
correlation between egg counts and immune 
responses of different antibody isotypes showed 
that relationship existed between immunoglobulin 
levels against SWAP, SEA antigens and egg count in 
before and after treatment. Most of anti SWAP and 
anti SEA (IgG4) immunoglobulins were positively 
correlated to egg counts in pre treatment sera except 
anti SWAP IgE, which was negatively correlated 
to all egg counts  in post treatment sera (2, 13). 
In conclusion we conclude that treatment with 
praziquantel caused changes in the levels of anti 
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SWAP and anti SEA (IgE and IgG4). Increase levels 
of anti SWAP, anti SEA IgE have been linked to 
resistance to reinfections after treatment. Likewise, 
decrease in levels of anti SWAP, anti SEA IgG4. This 
study illustrated increased levels of anti SWAP 
IgE and anti SEA IgE after a single oral dose of 
praziquantel treatment and decreased in levels of 
anti SWAP, anti SEA IgG4. It is therefore suggestive 
that the continuing S. mansoni negative observed after 
a single oral dose of praziquantel treatment in this 
study, is due to immune responses due to increase 
IgE and decrease in IgG4. Moreover, we also observed 
positive correlation between age and anti IgE and 
negative correlation between age and IgG4 after 
treatment. In addition, negative correlation between 
intensity and IgE antibody as opposed to positive 
correlation between intensity and IgG4 observed in 
this study further suggest that the resistance or the 
reinfection observed in this study was influenced 
by type and amount of antibodies produced by the 
antigens released from worms and eggs. Sex did 
not have any influence on the immunoglobulins. 
The long-term effect of immunological change in 
Kigungu needs further investigation using specific 
stage antigens in treatment re-infection study design 
to establish the nature and development of naturally 
acquired immunity at short intervals and compare 
findings with similar studies done elsewhere using 
stage specific antigens.
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